Connected Health and Wellness Solutions Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Connected Health and Wellness Solutions Market Trends and Insights

Increasing Chronic Disease Monitoring Demand

The connected health and wellness solutions market is being shaped by a disease burden that is persistent across both mature and developing healthcare systems. Noncommunicable diseases accounted for 74% of global annual mortality, and the WHO reported in 2025 that most countries were still off track on their reduction commitments. In the United States, CDC data published in 2025 showed that 74% of adults reported at least 1 chronic condition in 2023, while 51% reported multiple conditions, which reinforces demand for long-duration monitoring tools across the connected health and wellness solutions market.^{[1]Centers for Disease Control and Prevention, “Fast Facts, Health and Economic Costs of Chronic Conditions,” CDC, cdc.gov}A 2026 systematic review in JMIR also pointed back to the CDC finding that chronic disease spending consumes 90% of U.S. healthcare expenditure, which means the cost case for prevention and monitoring remains intact.^{[2]William David Strain et al., “Wearable Devices for Remote Monitoring of Chronic Diseases, Systematic Review,” JMIR mHealth and uHealth, jmir.org} This keeps demand in the connected health and wellness solutions market tied to a structural healthcare need rather than a short-cycle technology purchase, which supports more predictable revenue planning for platform operators.

Shift from Episodic Care to Continuous Wellness Management

The connected health and wellness solutions market is moving with a broader care model shift from reactive visits toward continuous patient management. Traditional visits only capture a short point in time, while connected devices can generate longitudinal data that helps teams identify deterioration earlier and follow patients between encounters. The FDA’s TEMPO pilot, launched in January 2026, shows that regulators now recognize the importance of digital tools that can demonstrate meaningful patient outcomes in routine care.^{[3].S. Food and Drug Administration, “510(k) Premarket Notification K250507, Hypertension Notification Feature, Apple Inc.,” FDA, accessdata.fda.gov} That policy signal favors the connected health and wellness market segments that already combine monitoring, virtual touchpoints, and evidence generation inside a single workflow. It also means that vendors collecting deeper longitudinal datasets can build a stronger position for future regulatory submissions and payer discussions than vendors that only provide isolated device readings.

Consumer Adoption of Wearables and Health Apps

The connected health and wellness solutions market is also benefiting from the way consumer devices are taking on clearer clinical roles. Apple received FDA 510(k) clearance in September 2025 for a hypertension notification feature on Apple Watch Series 11, which shows that large consumer platforms can now place regulated health functions inside mass market hardware. Dexcom also received FDA clearance in April 2025 for the G7 15 Day continuous glucose monitoring system, which expands the practical use case for connected monitoring in everyday disease management. As these products move closer to retail and over the counter access models, the connected health and wellness solutions market gains a wider front door for patient onboarding and recurring engagement. The next phase of growth in the connected health and wellness market will depend less on simple device ownership and more on how well these tools connect with clinical workflows, medication management, and personalized care plans.

Edge AI and Sensor Miniaturization Improve Clinical Utility

The connected health and wellness solutions market is gaining utility as edge AI reduces dependence on uninterrupted cloud connectivity. Local processing allows wearable devices to analyze signals on the device, shorten alert time, and reduce the amount of raw data that must move across networks. HL7 International then launched the Caliper FHIR Accelerator in 2026 to improve exchange standards for medical and personal health device data, which helps turn device output into something more actionable inside healthcare systems. As sensors become smaller and cheaper, the connected health and wellness solutions market will be able to extend monitoring functions into a wider range of devices and everyday settings.

Data Privacy, Cybersecurity, and Consent Friction

The connected health and wellness solutions market depends on continuous flows of biometric and behavioral data, and that makes trust a core adoption requirement. As more devices collect data outside hospitals and clinics, vendors must manage consent, identity, storage, and sharing expectations across multiple care settings. This slows deployment because providers do not only evaluate clinical performance, they also examine how a platform handles connected sensor data through the full care process. The same issue affects patients because long term adoption is harder when data use terms are unclear or when monitoring feels more intrusive than supportive. In the connected health and wellness solutions market, weak security design can therefore delay contracts, reduce utilization, and increase pressure on vendors to prove end to end governance before scale deployment.

Uneven Reimbursement and Device Validation Across Markets

The connected health and wellness solutions market still faces uneven reimbursement and validation pathways across countries, payer types, and care settings. CMS permanently embedded a simplified telehealth services framework in the 2026 Physician Fee Schedule, but Medicare’s broader telehealth flexibilities are only extended through December 31, 2027, after which many non-behavioral health services will again face geographic restrictions. That timeline is already pushing commercial strategies in the connected health and wellness solutions market toward value-based and employer-sponsored models that can hold up if fee-for-service access narrows. Outside the United States, many APAC and MEA markets still lack standardized reimbursement codes for wearable-generated data, which keeps revenue models more dependent on direct pay, employer benefits, or government programs.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Clinical Devices Hold Share as Wellness Hardware Scales Fast

Personal medical devices held 52.46% of connected health and wellness solutions market share in 2025, which kept this category in the lead because clinically validated hardware still moves through reimbursement backed procurement channels with more predictable pricing. This part of the connected health and wellness solutions market includes continuous glucose monitors, ambulatory cardiac monitors, and remote vital sign patches that already fit into established care pathways.

Wellness products are forecasted to grow at a 23.85% CAGR, and the connected health and wellness solutions market size for this segment is rising as sensor costs fall and access widens beyond tightly defined clinical use cases. Software and services still represent a smaller revenue base, but this is where the connected health and wellness solutions industry is building stronger moats as hardware becomes easier to compare across vendors. Providers and payers are placing more value on analytics, decision support, and integration features because those layers shape long term stickiness after the device sale.

By Function: Remote Patient Monitoring Anchors the Market as Telehealth Reshapes Care Delivery

Remote patient monitoring held 48.92% share in 2025, which reflects its established role in discharge protocols, chronic care management, and value-based programs that encourage care at home. The connected health and wellness solutions market has given RPM a strong commercial base because cardiology, pulmonology, and diabetes already have years of clinical validation behind continuous monitoring models. This makes RPM easier for providers to justify in budget cycles because the link to readmission reduction and follow-up adherence is clearer than in newer digital categories. It also keeps RPM closely tied to the parts of healthcare where cost avoidance can be measured more directly.

Telehealth is projected to expand at a 24.71% CAGR, and the connected health and wellness solutions market size tied to virtual care functions should keep rising as billing rules become easier to navigate. Clinical monitoring remains important in institutional settings, but alarm fatigue documented in ICU settings increases the need for better prioritization and signal filtering rather than more alerts alone.

By Application: Diagnosis Leads in Volume as Monitoring Applications Set the Growth Pace

Diagnosis and treatment accounted for 44.37% of revenue in 2025, which kept this application group ahead because cleared diagnostic devices command stronger pricing and reimbursement than broader wellness tools. In the connected health and wellness solutions market, this category benefits from a steady stream of new clinical indications that expand use without requiring an entirely new commercial logic. That kind of launch deepens the addressable patient pool while keeping regulated monitoring at the center of value creation.

Monitoring applications are forecasted to grow at a 25.28% CAGR, and the connected health and wellness solutions market size attached to this group is rising because continuous biometric collection fits population health and chronic care programs more closely than point-in-time testing. Platforms that gather long-duration data also gain an advantage in regulatory and coverage discussions because they can show outcomes over longer periods and across larger patient cohorts. Wellness and prevention and healthcare management remain smaller in current revenue, but they are strategically relevant entry points into employer benefits and cardiometabolic care.

By End User: Institutional Procurement Anchors Revenues as Homecare Grows Fastest

Hospitals and clinics held 46.18% share in 2025, which reflects the concentration of procurement budgets, evidence requirements, and multiyear contracting within acute care institutions. The connected health and wellness solutions market still relies on these settings for revenue leadership because regulated deployment, post-discharge monitoring, and clinical decision support carry higher per-patient value. Institutional buyers also prefer platforms that can show interoperability, security controls, and workflow fit before large rollouts. That combination keeps hospitals and clinics central even as growth gradually broadens into other settings.

Homecare settings are forecasted to expand at a 26.12% CAGR, and the connected health and wellness solutions market size linked to home use is increasing as aging-in-place preferences, workforce shortages, and hospital-at-home models gain more policy and operational support. The case for homecare is stronger when connected monitoring can keep patients out of high-cost settings without reducing follow-up quality or continuity. Ambulatory and specialty care are also expanding with outpatient chronic care trends, while Research and Diagnostics remain important because they help convert connected datasets into evidence that can widen adoption across the connected health and wellness solutions industry.

Geography Analysis

North America held 42.84% of connected health and wellness solutions market share in 2025, which kept the region in front because it combines a high concentration of FDA cleared devices with a more mature telehealth reimbursement base and a faster moving interoperability agenda. The Office of the National Coordinator’s Draft USCDI Version 7, released in January 2026, advances data standardization for wearable and device generated health data, and that will continue shaping platform design choices in the connected health and wellness solutions market. The United States remains the regional anchor because regulatory clarity, payer alignment, and enterprise health IT spending are all stronger than in most other markets.

The connected health and wellness solutions market in Europe is moving on a different path, with reimbursement design and cross border data governance playing a larger role in adoption. Germany’s DiGA framework remains one of the clearest prescription digital health reimbursement models for software led care in the region. The United Kingdom is continuing to use remote patient monitoring more actively in post acute cardiovascular and respiratory pathways as workforce pressure pushes care outside traditional settings. France, Italy, and Spain are still following rather than leading these platform adoption patterns, and investment remains linked to national health IT budget cycles. Across the region, the European Health Data Space and the EU Medical Device Regulation should gradually reduce fragmentation and support wider deployment, while recent device approvals.

Asia-Pacific is forecasted to grow at a 27.46% CAGR, and the connected health and wellness solutions market size in the region is being lifted by strong demographic demand, public digital health investment, and a deep consumer electronics manufacturing base. Government backed infrastructure and broader familiarity with mobile first services create a favorable environment for remote monitoring and virtual care expansion across the connected health and wellness solutions market. The Middle East and Africa and South America remain earlier stage, but GCC countries and Brazil stand out for near term potential even as legacy health IT systems continue to raise integration costs and slow rollout speed.